Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

노보 노디스크의 차세대 비만 치료제 카그리세마가 후기 임상 추가 분석에서 여성 평균 25% 체중 감소를 보여 긍정적입니다.

AI CATALYST SCORE65 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

NVO Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-10-20 22:03:40	NVO	85	Mid	View Report →
2026-10-20 13:08:34	NVO	65	Mid	View Report →
2026-10-02 21:48:45	NVO	40	Row	View Report →

RELATED REPORTS

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 21:09:52	AGEN	85	Mid	View Report →
2026-10-25 20:13:30	XNCR	80	Mid	View Report →
2026-10-25 19:00:44	GMAB	60	Mid	View Report →
2026-10-25 18:43:11	SMMT	85	Mid	View Report →
2026-10-25 16:22:07	AZN	82	Mid	View Report →
2026-10-25 12:05:03	MRNA	45	Mid	View Report →
2026-10-25 11:15:41	GMAB	50	Mid	View Report →
2026-10-25 08:49:05	XNCR	45	Mid	View Report →
2026-10-24 19:59:13	AMGN	62	Mid	View Report →
2026-10-24 18:08:27	ZYME	64	Mid	View Report →
2026-10-24 14:39:24	AMGN	90	Mid	View Report →
2026-10-24 14:16:22	LLY	65	Mid	View Report →
2026-10-24 12:28:05	MRNA	65	Mid	View Report →
2026-10-24 05:57:34	ALLO	30	Row	View Report →
2026-10-24 01:58:48	VRTX	60	Mid	View Report →
2026-10-23 20:03:59	BMY	45	Mid	View Report →
2026-10-23 19:12:59	IOVA	62	Mid	View Report →
2026-10-23 19:02:09	MRNA	50	Mid	View Report →
2026-10-23 16:30:29	MRNA	60	Mid	View Report →
2026-10-23 16:00:41	MRNA	45	Mid	View Report →
2026-10-23 14:52:37	ALNY	68	Mid	View Report →
2026-10-23 09:05:25	MRNA	25	Row	View Report →
2026-10-23 06:33:51	ZLAB	40	Row	View Report →
2026-10-23 02:12:35	UTHR	42	Row	View Report →
2026-10-23 01:00:24	RAPP	55	Mid	View Report →
2026-10-22 21:53:58	MRNA	50	Mid	View Report →
2026-10-22 19:42:35	MRNA	45	Mid	View Report →
2026-10-22 17:39:22	MRNA	45	Mid	View Report →
2026-10-22 15:17:00	MRNA	55	Mid	View Report →
2026-10-22 13:42:28	LNTH	45	Mid	View Report →